Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2020     2019     2020     2019  
Options to purchase common stock     1,060,254       1,585,634       1,060,254       1,585,634  
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO and Merger common stock purchase warrants     4,006,205       341,941       4,006,205       341,941  
Series H, H-3, H-6, and pre-merger AYRO Seed Preferred Stock     278,862       1,477,567       278,862       1,477,567  
Totals     5,345,321       3,405,142       5,345,321       3,405,142